仁景生物
仁景生物
  • Home
  • About Us
  • Pipeline
  • Platform
  • News & Announcements
    • News
    • Announcements
  • Careers
  • More
    • Home
    • About Us
    • Pipeline
    • Platform
    • News & Announcements
      • News
      • Announcements
    • Careers

  • Home
  • About Us
  • Pipeline
  • Platform
  • News & Announcements
    • News
    • Announcements
  • Careers

About Us

Established in 2021, RinuaGene Biotechnology Co., Ltd. is committed to the research and development of innovative mRNA therapeutics and vaccines. The company efficiently advances its FIC/BIC product pipeline and robust technological platform with a solid foundation in technical expertise, pharmaceutical industry experience, and managerial capabilities. Driven by innovation, RinuaGene is striving to build formidable international competitiveness.

Focus Areas

Key Platforms

Key Platforms

Preventive vaccines for infectious diseases, virus-related therapeutic vaccines, tumor immunotherapies, and protein replacement therapies.

Key Platforms

Key Platforms

Key Platforms

Optimization of linear mRNA and circular RNA design, efficient targeted delivery, robust CMC, data science, and AI for RNA.

Intellectual Property

Intellectual Property

Intellectual Property

A comprehensive international patent layouts that fully covers the product pipeline and technology platforms, with 74 invention patents and 3 software copyrights filed as of August 2024.

Team Development

Intellectual Property

Intellectual Property

Equipped with full-spectrum mRNA drug development capabilities, with 80% of the workforce engaged in R&D, and over 60% holding master's or doctoral degrees.

Mission

RinuaGene is dedicated to establishing a world-leading platform for innovative and efficient RNA therapeutics and vaccine technologies, to provide innovative and high-quality solutions to address critical health challenges in China and around the globe.

Honors

2023

2023

2023

 Innovation Project of "Revealing the List and Taking the Lead" in Cell Therapy of National Center of Technology Innovation for Biopharmaceuticals.

2023

2023

2023

Jiangsu Province "Entrepreneurship and Innovation" Entrepreneurial Talent.

2023

2023

2023

Jiangsu Province "Entrepreneurship and Innovation" Innovative Talent.

2023

2023

2023

Jiangsu "Potential Unicorn" Enterprise.

2023

2023

2023

Jiangsu Suzhou "Unicorn Cultivation" Enterprise.

2021

2023

2023

Gusu Leading Talent (Regional Key Talent).

2021

2021

2021

Suzhou Industrial Park Jinji Lake Talent.

© 2024 RinuaGene. All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept